John Maraganore - Director at Hemab Therapeutics Holdings, Inc.

Issuer-level insider activity

Role
Director
Issuer ticker
COAG on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by John Maraganore since 05 Aug 2025

Reported holdings for John Maraganore in Hemab Therapeutics Holdings, Inc.

Form 4 holding Director

Hemab Therapeutics Holdings, Inc.

Security class
Warrants (Right to Buy)
Shares / value
107,338
Estimated value
Report date
29 Jan 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Hemab Therapeutics Holdings, Inc.

Security class
Series B Preferred Stock
Shares / value
0
Estimated value
Report date
04 May 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Hemab Therapeutics Holdings, Inc.

Security class
Series C Preferred Stock
Shares / value
0
Estimated value
Report date
04 May 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for John Maraganore in Hemab Therapeutics Holdings, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .